Short answer
EyePoint, Inc. (EYPT) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $965,000 (down 90.8% year over year) with net income of −$60M.
Q3 2025 key financials · XBRL
- Revenue
- $965,000
- −90.8% YoY · −81.9% QoQ
- Net income
- −$60M
- −103.4% YoY · −0.5% QoQ
- Operating margin
- -6427.5%
- EPS (diluted)
- −$0.85
- −57.4% YoY · +0.0% QoQ
Source: XBRL data from the EyePoint, Inc. (EYPT) Q3 2025 10-Q on SEC EDGAR. USD.
EyePoint, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New DOJ investigation risk related to sales practices of DEXYCU®, triggered by subpoena received August 2022
- Most material update: ongoing DOJ discussions may require financial undertakings despite belief impact is immaterial
- Regulatory/legal risk: potential DOJ enforcement action with civil monetary penalties could materially harm financial condition
- Operational risk: significant ongoing resource allocation to DOJ subpoena response and settlement discussions impacting cash flows
- Financial risk: potential material adverse effects on results of operations and cash flows if DOJ action proceeds
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other EyePoint, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.